Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (21-30 of 824) with videos related to

Pageof 83
Sort By:
European Urology|January 1, 1996
Supportive care is not the only option in prostate cancer patients resistant to hormone therapy: the argument forH I Scher
Cancer|January 28, 2003
Prostate carcinoma: defining therapeutic objectives and improving overall outcomesHoward I Scher
Seminars in Oncology|October 1, 1994
Introduction: prostate cancerH I Scher
The Journal of Urology|November 1, 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaH I Scher
Current Opinion in Oncology|June 1, 1990
Predicting biologic potential in prostate cancerH I Scher
Lancet (London, England)|March 31, 2016
Defining new standards of care for men with prostate cancerHoward I Scher
The Journal of Urology|November 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACH I Scher
The Journal of Urology|November 1, 1995
A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancerH I Scher
The Journal of Urology|August 1, 1994
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancerH I Scher
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Current management of hormone-refractory prostate cancerHoward I Scher
Pageof 83

Showing results (21-30 of 824) with videos related to

Sort By:
Pageof 83
European Urology|January 1, 1996
Supportive care is not the only option in prostate cancer patients resistant to hormone therapy: the argument forH I Scher
Cancer|January 28, 2003
Prostate carcinoma: defining therapeutic objectives and improving overall outcomesHoward I Scher
Seminars in Oncology|October 1, 1994
Introduction: prostate cancerH I Scher
The Journal of Urology|November 1, 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaH I Scher
Current Opinion in Oncology|June 1, 1990
Predicting biologic potential in prostate cancerH I Scher
Lancet (London, England)|March 31, 2016
Defining new standards of care for men with prostate cancerHoward I Scher
The Journal of Urology|November 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACH I Scher
The Journal of Urology|November 1, 1995
A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancerH I Scher
The Journal of Urology|August 1, 1994
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancerH I Scher
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Current management of hormone-refractory prostate cancerHoward I Scher
Pageof 83